Learn About Raynaud Phenomenon

What is the definition of Raynaud Phenomenon?

Raynaud phenomenon is a condition in which cold temperatures or strong emotions cause blood vessel spasms. This blocks blood flow to the affected regions and causes discoloration.

What are the alternative names for Raynaud Phenomenon?

Raynaud disease; Primary Raynaud; Secondary Raynaud

What are the causes of Raynaud Phenomenon?

When Raynaud phenomenon is a primary condition, meaning it occurs by itself and not in association with other diseases, it is referred to as Raynaud disease. It most often begins in women younger than age 30. Secondary Raynaud phenomenon is when the condition is linked to other conditions and can occur at any age.

Common causes of secondary Raynaud phenomenon are:

  • Diseases of the arteries (such as atherosclerosis)
  • Medicines that cause narrowing of arteries (such as amphetamines, certain types of beta-blockers, some cancer medicines, certain medicines used for migraine headaches)
  • Arthritis and autoimmune conditions (such as scleroderma, Sjögren syndrome, rheumatoid arthritis, vasculitis, Buerger disease and systemic lupus erythematosus)
  • Certain blood disorders, such as cold agglutinin disease or cryoglobulinemia
  • Repeated injury or usage such as from heavy use of hand tools or vibrating machines
  • Smoking
  • Frostbite
  • Thoracic outlet syndrome
What are the symptoms of Raynaud Phenomenon?

Exposure to the cold or strong emotions bring on the changes.

  • First, the affected areas become white, and then turn blue. Fingers are most commonly involved, but toes, ears, lips or the nose can also change color as well.
  • When blood flow returns, the area becomes red and then later returns to normal color.
  • The attacks may last from minutes to hours.

People with Raynaud disease have problems in the same fingers on both sides. Most people do not have much pain. The skin of the arms or legs may develop bluish blotches which goes away when the skin is warmed up.

People with secondary Raynaud phenomenon are more likely to have pain or tingling in the fingers. Painful ulcers may form on the affected fingers if the attacks are severe.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Raynaud Phenomenon?

Taking these steps may help control Raynaud phenomenon:

  • Keep the body part warm. Avoid exposure to cold in any form. Wear mittens or gloves outdoors and when handling ice or frozen food. Avoid getting chilled, which may happen after any active recreational sport.
  • Stop smoking. Smoking causes blood vessels to narrow even more.
  • Avoid caffeine.
  • Avoid taking medicines that cause blood vessels to tighten or spasm.
  • Wear comfortable, roomy shoes and wool socks. When outside, always wear shoes.

Your provider may prescribe medicines to dilate the walls of the blood vessels. These include topical nitroglycerin cream that you rub on your skin, calcium channel blockers, sildenafil (Revatio), and tadalafil (Adcirca).

Low dose aspirin is often used to prevent blood clots.

For severe disease (such as when gangrene begins in fingers or toes), intravenous medicines may be used. Surgery may also be done to cut nerves that cause spasm in the blood vessels. People are most often hospitalized when the condition is this serious.

It is vital to treat the condition causing Raynaud phenomenon.

Who are the top Raynaud Phenomenon Local Doctors?
Robyn T. Domsic
Elite in Raynaud Phenomenon
Rheumatology
Elite in Raynaud Phenomenon
Rheumatology

UPMC St. Margaret Rheumatology

200 Delafield Road, St Margaret Medical Arts Bldg, Suite 4040, 
Pittsburgh, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Robyn Domsic, MD, specializes in rheumatology and is certified by the American Board of Internal Medicine. She practices at University of Pittsburgh Physicians, Department of Medicine, Division of Rheumatology and is affiliated with UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Mercy. She completed her medical degree at University of Iowa College of Medicine. Dr. Domsic is rated as an Elite provider by MediFind in the treatment of Raynaud Phenomenon. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Elite in Raynaud Phenomenon
Elite in Raynaud Phenomenon
Milan, IT 

Francesca Ingegnoli practices in Milan, Italy. Ms. Ingegnoli is rated as an Elite expert by MediFind in the treatment of Raynaud Phenomenon. Her top areas of expertise are Raynaud Phenomenon, Systemic Sclerosis (SSc), Scleroderma, Rheumatoid Arthritis (RA), and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Raynaud Phenomenon
Elite in Raynaud Phenomenon
Genoa, IT 

Maurizio Cutolo practices in Genoa, Italy. Mr. Cutolo is rated as an Elite expert by MediFind in the treatment of Raynaud Phenomenon. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Arthritis.

What is the outlook (prognosis) for Raynaud Phenomenon?

The outcome varies. It depends on the cause of the problem and how bad it is.

What are the possible complications of Raynaud Phenomenon?

Complications may include:

  • Gangrene or skin ulcers may occur if an artery becomes completely blocked. This problem is more likely in people who also have arthritis or autoimmune conditions.
  • Fingers may become thin and tapered with smooth shiny skin and nails that grow slowly. This is due to the poor blood flow to the areas.
When should I contact a medical professional for Raynaud Phenomenon?

Contact your provider if:

  • You have a history of Raynaud phenomenon and the affected body part (hand, foot, or other part) becomes infected or develops a sore.
  • Your fingers change color, especially white or blue, when they are cold and don't return to their usual color.
  • Your fingers or toes turn black or the skin breaks down.
  • You have a sore on the skin of your feet or hands which does not heal.
  • You have a fever, swollen or painful joints, or skin rashes.
What are the latest Raynaud Phenomenon Clinical Trials?
Double Blind RCT to Evaluate the Effect of Botulinum Toxin in Raynaud Phenomenon

Summary: Raynaud's Phenomenon (RP) is the most common vasospastic disorder encountered by hand surgeons with an estimated prevalence of 5% in the general population. It's manifestations are broad, and can range from minor to severe. Sometimes it can be refractory to treatments. The goal of this study is to evaluate the efficacy of Botulinum toxin (BT) in the treatment of treatment refractory RP by objectiv...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)

Summary: The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked by patients as affecting qualify of life (fatigue, Raynaud phenomenon) as co-primary outcomes.

Who are the sources who wrote this article ?

Published Date: April 01, 2025
Published By: Diane M. Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Bartholomew JR. Other peripheral arterial diseases. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 66.

Landry GJ, Repella TL. Raynaud phenomenon. In: Sidawy AN, Perler BA, eds. Rutherford's Vascular Surgery and Endovascular Therapy. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 142.

St. Clair EW, Leverenz DL. Sjögren's syndrome. In: Firestein GS, McInnes IB, Koretzky GA, Mikuls TR, Neogi T, O'Dell JR, eds. Firestein & Kelley's Textbook of Rheumatology. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 74.

Varga J. Systemic sclerosis (scleroderma). In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 246.